The new model for equitable access in LMICs: From initiative to integrated ecosystems

Published on December 2, 2026

Access in low- and middle-income countries (LMICs) has long depended on donor-funded programs, one-off partnerships, and isolated pricing initiatives. While these approaches delivered varying levels of success, they were not designed for scale or sustainability. With more than 80% of the world’s population living in LMICs, equitable access is becoming a strategic necessity for pharmaceutical companies, driven by rising disease burden and demand for innovation.

In this webinar, we unpack findings from our latest whitepaper and explore how leading companies are shifting from fragmented initiatives to integrated access ecosystems. Drawing on real-world examples from senior industry leaders, the session highlights the six strategic levers to navigate access in the region: early planning, market prioritization, ecosystem design…

lmci_